ANDAORALTABLET
Approved
Nov 2018
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
20
Mechanism of Action
Aromatase Inhibitors
Pharmacologic Class:
Aromatase Inhibitor
Clinical Trials (5)
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Started Apr 2025
450 enrolled
Breast Cancer
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
Started Jan 2025
1,020 enrolled
Breast Cancer
ALPINE: Maintenance Letrozole/Abemaciclib
Started Sep 2024
32 enrolled
Endometrial CancerRecurrent Endometrial CancerTP53
A Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Women Post Menopause
Started Jul 2024
121 enrolled
Breast Cancer
Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer
Started Nov 2023
100 enrolled
Low Grade Serous Ovarian CarcinomaAdult Type Granulosa Cell Tumor